Abstracts Archive - Page 2162 of 2607 - ACR Meeting Abstracts

Abstract Number: 1067 • 2014 ACR/ARHP Annual Meeting
Mortality Trends in Rheumatoid Arthritis during the Biologic Era, 1998 to 2011
Bryant R. England¹, Harlan Sayles², Ted R. Mikuls² and Kaleb Michaud^1,3, ¹Internal Medicine, University of Nebraska Medical Center, Omaha, NE, ²Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, ³National Data Bank for Rheumatic Diseases, Wichita, KS
Background/Purpose: Rheumatoid arthritis (RA) has consistently been associated with increased mortality risk, a risk that appears to be linked with greater disease activity. Although there…
Abstract Number: 1066 • 2014 ACR/ARHP Annual Meeting
Factors Associated with Recording of Rheumatoid Arthritis on Death Certificate
Emily Molina¹, Jose Felix Restrepo², Inmaculada del Rincon¹, Daniel Battafarano³ and Agustin Escalante⁴, ¹Rheumatology, University of Texas Health Science Center, San Antonio, TX, ²Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX, ³Rheumatology, San Antonio Military Medical Center, JBSA - Ft Sam Houston, TX, ⁴Medicine-Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX
Factors Associated with Recording of Rheumatoid Arthritis on Death Certificates Background/Purpose: Death certificates can be used to study mortality due to a particular disease. However, rheumatoid…
Abstract Number: 1065 • 2014 ACR/ARHP Annual Meeting
Characteristics of Rheumatoid Arthritis Patients with and without Cardiovascular Diseases – Data from the Ontario Best Practice Research Initiative (OBRI)
Kangping Cui^1,2, Binu Jacob³, Janet E. Pope⁴, Jessica Widdifield⁵, Xiuying Li³, Bindee Kuriya⁶, Pooneh Akhavan⁷ and Claire Bombardier⁶, ¹Faculty of Medicine, University of Toronto, Toronto, ON, Canada, ²University Health Network/Toronto General Hospital Research Institute, Toronto, ON, Canada, ³University Health Network, Toronto General Research Institute, Toronto, ON, Canada, ⁴Medicine, Divsion of Rheumatology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada, ⁵Institute for Clinical Evaluative Science, Toronto, ON, Canada, ⁶Rheumatology, University of Toronto, Toronto, ON, Canada, ⁷Medicine, Mount Sinai Hospital/University of Toronto, Toronto, ON, Canada
Background/Purpose Cardiovascular disease (CVD) is a major comorbidity and the leading cause of death among patients with rheumatoid arthritis (RA). The aim of this study…
Abstract Number: 1064 • 2014 ACR/ARHP Annual Meeting
Unique Profile of Cardiovascular Risk Factors in Rheumatoid Arthritis High-Risk Populations with Insufficient Risk Control
Ulf Müller-Ladner¹, Stefan Kleinert², Klaus Krüger³, Bianca Wittig⁴ and Rolf Hecker⁴, ¹Rheumatologie und klinische Immunologie, Kerckhoff-Klinik GmbH, Abt. Rheumatologie und klinische Immunologie, Bad Nauheim, Germany, ²Rheumatologie, Praxisgemeinschaft Rheumatologie-Nephrologie, Rheumatologische Schwerpunktpraxis, Erlangen, Germany, ³Praxiszentrum St. Bonifatius, München, Germany, ⁴Abbvie Deutschland GmbH & Co. KG, Wiesbaden, Germany
Background/Purpose More than 50% of premature deaths in patients with rheumatoid arthritis (RA) are due to cardiovascular disease (CVD). Both the cumulative burden of inflammation…
Abstract Number: 1063 • 2014 ACR/ARHP Annual Meeting
Management of Hyperlipidemia Among Patients with Rheumatoid Arthritis in the Primary Care Setting
Kashif Jafri¹, Lynne Taylor², Nehal N. Mehta³, Melissa Nezamzadeh⁴, Joshua Baker⁵ and Alexis Ogdie⁶, ¹Department of Medicine, University of Pennsylvania, Philadelphia, PA, ²Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, ³Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, PA, ⁴University of Pennsylvania, Philadelphia, PA, ⁵Medicine/Rheumatology, University of Pennsylvania and Philadelphia VAMC, Philadelphia, PA, ⁶Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA
Background/Purpose: Rheumatoid arthritis has been associated with an increased risk of cardiovascular morbidity and mortality. It is unclear, however, whether this knowledge has translated into…
Abstract Number: 1062 • 2014 ACR/ARHP Annual Meeting
Impact of Obesity on 1 Year Outcomes: Results from the Meteor Foundation International Rheumatoid Arthritis Cohort
Christopher Sparks¹, Robert Moots¹, Eftychia Psarelli², Tom Huizinga³ and Nicola Goodson¹, ¹Musculoskeletal Biology1, University of Liverpool, Liverpool, United Kingdom, ²Cancer Research UK Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, United Kingdom, ³Rheumatology, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose Increased adiposity is associated with increased production of pro-inflammatory adipokines and raised inflammatory markers. As a result, standard disease activity scores (DAS) may be…
Abstract Number: 1061 • 2014 ACR/ARHP Annual Meeting
How Does Rheumatoid Arthritis Disease Activity Affect Development of Upper Cervical Lesions? a Retrospective Study of Cervical Spine X-Rays Combined with a Cohort Study in Rheumatoid Arthritis Patients
Osamu Ishida^1,2, Katsunori Ikari³, Eisuke Inoue³, Atsuo Taniguchi⁴, Shigeki Momohara¹ and H. Yamanaka³, ¹Orthopedics, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ²Orthopedics, Kyoto City Hospital, Kyoto, Japan, ³Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ⁴Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
Background/Purpose It is believed that 40% to 80% of patients with rheumatoid arthritis (RA) have cervical spine lesions. In particular, atlantoaxial subluxation (AAS) and vertical…
Abstract Number: 1080 • 2014 ACR/ARHP Annual Meeting
Stroke Risks Among U.S. Medicaid Recipients with Systemic Lupus Erythematosus, 2000-2006: Racial and Ethnic Variation
Medha Barbhaiya¹, Jose A Gomez-Puerta², Hongshu Guan³, Daniel H. Solomon¹, Joanne M. Foody⁴, Graciela S. Alarcon⁵ and Karen H. Costenbader¹, ¹Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ²Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, Boston, MA, ³Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ⁴Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, ⁵Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose SLE patients are at increased stroke risk, but racial/ethnic variation in risk has not been examined in a population-based study. We examined risks by…
Abstract Number: 1079 • 2014 ACR/ARHP Annual Meeting
Prevalence of Cardiac Arrhythmias in Systemic Lupus Erythematosus
Gihyun Myung¹, Lindsy J. Forbess², Mariko L. Ishimori², Sumeet Chugh¹, Daniel Wallace¹ and Michael H. Weisman¹, ¹Cedars-Sinai Medical Center, Los Angeles, CA, ²Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA
Background/Purpose Cardiovascular disease is a major cause of death among systemic lupus erythematosus (SLE) patients. Although the prevalence of atrial fibrillation (0.5-1%) and QT prolongation…
Abstract Number: 1078 • 2014 ACR/ARHP Annual Meeting
Work-Related Behavior and Experiences in Patients with Systemic Lupus Erythematosus
Jutta G. Richter¹, Ralph Brinks², Thomas Muth³, Tobias Koch¹, Peter Angerer³ and Matthias Schneider⁴, ¹Department of Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, ²Department of Rheumatology, Heinrich-Heine-University Duesseldorf, Düsseldorf, Germany, ³Institute for Occupational and Social Medicine, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, ⁴Department of Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
Background/Purpose: Work-related behavior and experiences are discussed to be either risk factors or resources for individual‘s health. Diseases and related changing working conditions and/or experiences…
Abstract Number: 1077 • 2014 ACR/ARHP Annual Meeting
A Real-World Characterization of US Patients with “Moderate-to-Severe” Systemic Lupus Erythematosus
Vibeke Strand¹, Jennifer Johnson², Carl Vandeloo³, Catrinel Galateanu³ and Steve Lobosco², ¹Biopharmaceutical Consultant, Portola Valley, CA, ²Adelphi Real World Ltd., Macclesfield, United Kingdom, ³UCB Pharma, Brussels, Belgium
Background/Purpose Systemic lupus erythematosus (SLE) is a chronic, inflammatory disease which can impact on patients' Health-Related Quality of Life (HRQoL). This analysis was designed to…
Abstract Number: 1076 • 2014 ACR/ARHP Annual Meeting
U.S. Geographic Trends in the Distribution and Treatment Practices of Juvenile Systemic Lupus Erythematosus: An Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry
Jennifer M.P. Woo^1,2, Ornella J. Rullo¹, Deborah K. McCurdy³ and The CARRA Registry Investigators⁴, ¹Pediatric Rheumatology, University of California, Los Angeles, Los Angeles, CA, ²Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI, ³Pediatric Rheumatology, UCLA Division of Pediatric Rheumatology, Los Angeles, CA, ⁴Childhood Arthritis and Rheumatology Research Alliance, Durham, NC
Background/Purpose: The treatment of juvenile systemic lupus erythematosus (jSLE) often requires complex medication regimens in order to address the different disease manifestations. Despite the limited…
Abstract Number: 1074 • 2014 ACR/ARHP Annual Meeting
A Meta-Analysis of the Risk of Venous Thromboembolism in Inflammatory Rheumatic Diseases
Jason J Lee¹ and Janet E. Pope², ¹Medicine/Rheumatology, University of Western Ontario, London, ON, Canada, ²St Joseph Health Care, London, ON, Canada
Background/Purpose: We performed a meta-analysis investigating the risk of developing deep vein thrombosis (DVT) and/or pulmonary embolisms (PE) in patients with inflammatory arthritis, vasculitis, and…
Abstract Number: 1075 • 2014 ACR/ARHP Annual Meeting
Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Women with Systemic Lupus Erythematosus on Immunosuppressive Drugs
Candace H. Feldman¹, Jun Liu², Sarah Feldman³, Daniel H. Solomon⁴ and Seoyoung C. Kim⁵, ¹Rheumatology, Brigham and Women's Hospital, Boston, MA, ²Division of Pharmaoepidemiology, Brigham and Women's Hospital, Boston, MA, ³Brigham and Women's Hospital, Boston, MA, ⁴Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁵Div. of Pharmacoepidemiology and Pharmacoeconomics, Div. of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Human papillomavirus (HPV) is the most common sexually transmitted disease in the US and the main cause of high-grade cervical dysplasia and cervical cancer.…
Abstract Number: 1055 • 2014 ACR/ARHP Annual Meeting
Identifying Flare in Rheumatoid Arthritis (RA): Performance of the Flare-Assessment in RA (FLARE) Questionnaire in a US Population
Elena Myasoedova¹, Cynthia S. Crowson², Bruno Fautrel³, Francis Guillemin⁴, Eric L. Matteson⁵ and Sherine E. Gabriel⁶, ¹Internal Medicine and Rheumatology, Mayo Clinic, Rochester, MN, ²Health Sciences Research, Mayo Clinic, Rochester, MN, ³Rheumatology, UPMC GRC08, Paris 06 University, Pitié Salpétrière Hospital, Paris, France, ⁴Nancy University Hospital, Nancy, France, ⁵Rheumatology, Mayo Clinic, Rochester, MN, ⁶Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose Flare is an important aspect of rheumatoid arthritis (RA) patients’ disease experience with a crucial impact on quality of life and well-being. The flare-assessment…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].